TW202204394A - 腺病毒之免疫測定方法及免疫測定器具 - Google Patents
腺病毒之免疫測定方法及免疫測定器具 Download PDFInfo
- Publication number
- TW202204394A TW202204394A TW110113504A TW110113504A TW202204394A TW 202204394 A TW202204394 A TW 202204394A TW 110113504 A TW110113504 A TW 110113504A TW 110113504 A TW110113504 A TW 110113504A TW 202204394 A TW202204394 A TW 202204394A
- Authority
- TW
- Taiwan
- Prior art keywords
- adenovirus
- antibody
- antigen
- monoclonal antibody
- immunoassay
- Prior art date
Links
- 241000701161 unidentified adenovirus Species 0.000 title claims abstract description 83
- 238000003018 immunoassay Methods 0.000 title claims abstract description 34
- 239000000427 antigen Substances 0.000 claims abstract description 41
- 102000036639 antigens Human genes 0.000 claims abstract description 41
- 108091007433 antigens Proteins 0.000 claims abstract description 41
- 238000009739 binding Methods 0.000 claims abstract description 33
- 239000012634 fragment Substances 0.000 claims abstract description 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- 229920001184 polypeptide Polymers 0.000 claims abstract description 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims description 35
- 239000007790 solid phase Substances 0.000 claims description 7
- 238000002372 labelling Methods 0.000 claims description 3
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 12
- 230000003263 anti-adenoviral effect Effects 0.000 description 34
- 150000001413 amino acids Chemical group 0.000 description 18
- 241000700605 Viruses Species 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000002245 particle Substances 0.000 description 10
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 101710094396 Hexon protein Proteins 0.000 description 6
- 241000193096 Human adenovirus B3 Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 230000002163 immunogen Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920000136 polysorbate Polymers 0.000 description 6
- 206010001257 Adenoviral conjunctivitis Diseases 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 208000021373 epidemic keratoconjunctivitis Diseases 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 201000006476 shipyard eye Diseases 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 208000005577 Gastroenteritis Diseases 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- -1 polyethylene terephthalate Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108700026758 Adenovirus hexon capsid Proteins 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 241000342334 Human metapneumovirus Species 0.000 description 2
- 241000713196 Influenza B virus Species 0.000 description 2
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003505 heat denaturation Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 208000010370 Adenoviridae Infections Diseases 0.000 description 1
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000709714 Echovirus E11 Species 0.000 description 1
- 241000709638 Echovirus E6 Species 0.000 description 1
- 241000709643 Echovirus E9 Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000701149 Human adenovirus 1 Species 0.000 description 1
- 241001135563 Human adenovirus 19 Species 0.000 description 1
- 241000509400 Human adenovirus D37 Species 0.000 description 1
- 241001428586 Human adenovirus D8 Species 0.000 description 1
- 241001135572 Human adenovirus E4 Species 0.000 description 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
- 241000726041 Human respirovirus 1 Species 0.000 description 1
- 241000712003 Human respirovirus 3 Species 0.000 description 1
- 241001559187 Human rubulavirus 2 Species 0.000 description 1
- 241001559186 Human rubulavirus 4 Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000037950 acute febrile pharyngitis Diseases 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 201000001033 conjunctival folliculosis Diseases 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000012006 liquid chromatography with tandem mass spectrometry Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000005829 trimerization reaction Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/075—Adenoviridae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020073236A JP7291659B2 (ja) | 2020-04-16 | 2020-04-16 | アデノウイルスの免疫測定方法及び免疫測定器具 |
| JP2020-073236 | 2020-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202204394A true TW202204394A (zh) | 2022-02-01 |
Family
ID=78084558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110113504A TW202204394A (zh) | 2020-04-16 | 2021-04-15 | 腺病毒之免疫測定方法及免疫測定器具 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230176055A1 (enExample) |
| EP (1) | EP4116323A4 (enExample) |
| JP (3) | JP7291659B2 (enExample) |
| KR (1) | KR20220167285A (enExample) |
| CN (1) | CN115362170A (enExample) |
| TW (1) | TW202204394A (enExample) |
| WO (1) | WO2021210632A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116789807B (zh) * | 2023-06-14 | 2024-01-16 | 珠海重链生物科技有限公司 | 抗腺病毒单克隆抗体及其应用 |
| CN120309720B (zh) * | 2025-06-11 | 2025-09-02 | 北京溯本源和生物科技有限公司 | 一种用于5型腺病毒特异性检测单克隆抗体的组合及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000290298A (ja) | 1999-04-06 | 2000-10-17 | Toagosei Co Ltd | アデノウイルスに反応するモノクローナル抗体及びこれを用いたアデノウイルス検出法 |
| JP2000290299A (ja) | 1999-04-07 | 2000-10-17 | Toagosei Co Ltd | モノクローナル抗体及びこれを用いたアデノウイルス検出法 |
| JP4339906B2 (ja) | 2006-10-19 | 2009-10-07 | デンカ生研株式会社 | 試料ろ過フィルターを用いる簡易メンブレンアッセイ方法及びキット |
| CN108794622A (zh) * | 2017-05-02 | 2018-11-13 | 广州医科大学附属第医院 | 一种人3型腺病毒的中和性人源化单克隆抗体及其制备方法和应用 |
-
2020
- 2020-04-16 JP JP2020073236A patent/JP7291659B2/ja active Active
-
2021
- 2021-04-15 TW TW110113504A patent/TW202204394A/zh unknown
- 2021-04-15 EP EP21788631.6A patent/EP4116323A4/en active Pending
- 2021-04-15 CN CN202180028573.3A patent/CN115362170A/zh active Pending
- 2021-04-15 KR KR1020227035454A patent/KR20220167285A/ko active Pending
- 2021-04-15 US US17/919,065 patent/US20230176055A1/en active Pending
- 2021-04-15 WO PCT/JP2021/015540 patent/WO2021210632A1/ja not_active Ceased
-
2023
- 2023-01-20 JP JP2023007332A patent/JP7671791B2/ja active Active
-
2024
- 2024-08-22 JP JP2024140817A patent/JP2024157042A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115362170A (zh) | 2022-11-18 |
| WO2021210632A1 (ja) | 2021-10-21 |
| JP2024157042A (ja) | 2024-11-06 |
| JP2021168618A (ja) | 2021-10-28 |
| US20230176055A1 (en) | 2023-06-08 |
| JP2023052742A (ja) | 2023-04-12 |
| EP4116323A4 (en) | 2024-01-24 |
| KR20220167285A (ko) | 2022-12-20 |
| JP7291659B2 (ja) | 2023-06-15 |
| JP7671791B2 (ja) | 2025-05-02 |
| EP4116323A1 (en) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024157042A (ja) | アデノウイルスの免疫測定方法及び免疫測定器具 | |
| JP7455947B2 (ja) | アデノウイルスの免疫測定方法及び免疫測定器具 | |
| CN114729032A (zh) | 识别抗rs病毒的抗体、以及使用了该抗体的免疫测定方法及免疫测定仪器 | |
| TW202214681A (zh) | 腺病毒之免疫測定方法及免疫測定器具 | |
| JP7746495B2 (ja) | アデノウイルスの免疫測定方法及び免疫測定器具 | |
| JP2024003083A (ja) | Ｒｓウイルスを検出するための検出用試薬又はキット及びｒｓウイルスを検出する方法 | |
| JP2023181275A (ja) | マイコプラズマ・ニューモニエの免疫測定方法及び免疫測定器具 |